General Information


DRAVP ID  DRAVPe02279

Peptide Name   mCRAMP

Sequence  GLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPEQ

Sequence Length  34

UniProt ID  A0A8C6H0U3 

Taxon ID  10103 

Source  Adult testis, spleen, stomach, and intestine, Mice, M. musculus

Validation   Experimentally Validated



Origin Information


Gene Name/ID  Not Found

GenBank  Not Found

Amino Acid position  140-173

Domain Accession ID  Not Available

Nucleotide sequence ID  Not Available

Molecular Type  Not Found

Chromosomal Position  Primary_assembly QGOO01036336.1: 6,325-8,294 forward strand.



Activity Information


Target Organism  RSV,ZIKV

Assay  Antiviral Assay

Activity 

  • [Ref:35038500]ZIKV:IC50=At 5, 10, 20 μg/mL concentrtion attenuated ZIKV CPE by 39.8%, 68.9%, 90.1%, respectively.

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity  No cytotoxicity information found in the reference(s) presented

Binding Target  Not Found

Mechanism  CRAMP can combat ZIKV outside cells, and consequently inhibit viral attachment and entry.Cathelicidin CRAMP significantly inhibited the attachment and entry of ZIKV in Vero cells



Structure Information


PDB ID  None

Predicted Structure Download 

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C178H302N50O46

Absent amino acids  ACDHMOSTUWY

Common amino acids  K

Mass  3878.66

Pl  10.22

Basic residues  9

Acidic residues  3

Hydrophobic residues  10

Net charge  6

Boman Index  1.74

Hydrophobicity  -0.894

Aliphatic Index  88.82

Half Life 

  •     Mammalian:30hours
  •     Yeast:>20hours
  •     E.coli:>10hours

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  17



Literature Information


Literature 1

Title   Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans

Pubmed ID   26873992

Reference   Journal of immunology (Baltimore, Md. : 1950), 196(6), 2699–2710

Author   Currie, S. M., Gwyer Findlay, E., McFarlane, A. J., Fitch, P. M., Böttcher, B., Colegrave, N., Paras, A., Jozwik, A., Chiu, C., Schwarze, J., & Davidson, D. J. (2016)

DOI   10.4049/jimmunol.1502478

Literature 2

Title   Endogenous cathelicidin is required for protection against ZIKV-caused testis damage via inactivating virons

Pubmed ID   35038500

Reference   Antiviral research, 198, 105248.

Author   Liu, Z., Wu, J., Qin, Z., Dong, C., Yang, H., Sun, J., Xu, W., & Wei, L. (2022)

DOI   10.1016/j.antiviral.2022.105248